Skip to content

Evaluation of the Prevalence of Asthma in a Cohort of Children Born After IVF (Aged 11-15) Compared With a Control Group

Evaluation of the Prevalence of Asthma in a Cohort of Children Born After In Vitro Fertilization (Aged 11-15) Compared With Spontaneously Conceived Children of the Same Age Range

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02636179
Acronym
EMCeFIV
Enrollment
1792
Registered
2015-12-21
Start date
2015-12-31
Completion date
2017-09-30
Last updated
2015-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

In Vitro Fertilization, follow-up of children

Brief summary

Assisted Reproduction Technologies (ART) are increasingly being used worldwide as a result of fertility decline likely caused by changes in both environment and social behaviour. Considering this large usage, it is important to evaluate the potential risk on the health of children conceived using ART. According to the literature, children born after ART are more likely to be at higher risk of health problems than spontaneously conceived ones. Interestingly, recent studies suggested an increase of asthma prevalence in children conceived using In Vitro Fertilization (IVF). The purpose of this study is to evaluate the prevalence of asthma in school adolescents from a cohort of children born after In Vitro Fertilization (IVF), aged 11-15 years as compared to a control group composed of the same age range spontaneously conceived individuals. The expected outcome of this study will provide new information regarding these children to ART professionals of and to their own families, by focusing on an age range (between 11 and 15 years) for which very little information is available to date.

Detailed description

The methodology is a comparative epidemiological survey, between children from a historical cohort born after intraconjugal In Vitro Fertilization (singleton or twin) aged 11-15 years and a control group recruited in schools after the agreement of Academic Inspection. Parents of the two groups will be contacted either by phone calls or through written information given in the schools. They will receive the questionnaire and an information letter, once they give their agreement to be a part of the study. Data collection will be conducted using two anonymous questionnaires. The first questionnaire was built based on items proposed in the international Health Behaviour in School-aged Children (HBSC) survey of the World Health Organization (WHO). The second questionnaire will be sent to parents. It will focus on the pregnancy and it will be used to adjust the analysis. This study was submitted and approved by an Institutional Review Board in France (Comité de Protection des Personnes Sud-Méditerranée II) on 11th September 2015.

Interventions

OTHERComparative epidemiological survey

The method used to select the control group will be the random sampling of eligible schools. It will be defined according to the place of schooling of the historic cohort of children. The children will be matched as close as possible based on sex, age, school class and type of school (public/private).

Sponsors

Hospital St. Joseph, Marseille, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
11 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Case : * Children conceived by Intraconjugal In Vitro Fertilization/Intracytoplasmic Sperm Injection treatment * Children aged 11-15 years * Singleton and twins * School children * Control : * Children born spontaneously (without IVF) * Children aged 11-15 years * Children in the same place of schooling of the case

Exclusion criteria

* Case : * Children not born by Intraconjugal In Vitro Fertilization/Intracytoplasmic Sperm Injection treatment (donor) * Children whose parents refuse the participation * Triplet and more pregnancies * Children who cannot attend ordinary school * Children from families where an infant has passed away * When the participation agreement was not signed * Control : * Children whose parents have benefited ART * When the participation agreement was not signed * Children whose aged and sex are unknown * Triplet and more pregnancies

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of asthma15 month(will be assessed using the questionnaire of international Health Behaviour in School-aged Children \[HBSC\] survey).

Secondary

MeasureTime frameDescription
Prevalence of chronic diseases other than asthma15 month(will be assessed using the questionnaire of international Health Behaviour in School-aged Children \[HBSC\] survey)
Physical well-being15 month(will be assessed using the questionnaire of international Health Behaviour in School-aged Children \[HBSC\] survey)
Anthropometric measures15 month(will be assessed using the questionnaire of international Health Behaviour in School-aged Children \[HBSC\] survey)
Age of puberty in girls15 month(will be assessed using the questionnaire of international Health Behaviour in School-aged Children \[HBSC\] survey)

Countries

France

Contacts

Primary ContactMarie Raffray, MS
mraffray@hopital-saint-joseph.fr+33 491 80 65 16

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026